Home/Filings/4/0001415889-25-022524
4//SEC Filing

Yan Ming 4

Accession 0001415889-25-022524

CIK 0001831915other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 5:58 PM ET

Size

26.0 KB

Accession

0001415889-25-022524

Insider Transaction Report

Form 4
Period: 2025-08-18
Yan Ming
DirectorCHIEF TECHNOLOGY OFFICER
Transactions
  • Tax Payment

    Common Stock

    2025-08-18$4.06/sh2,184$8,8676,048,698 total
  • Exercise/Conversion

    Common Stock

    2025-08-18+6,1626,058,887 total
  • Exercise/Conversion

    Common Stock

    2025-08-18+1,9816,044,107 total
  • Tax Payment

    Common Stock

    2025-08-18$4.06/sh588$2,3876,043,519 total
  • Exercise/Conversion

    Common Stock

    2025-08-18+7,3636,050,882 total
  • Exercise/Conversion

    Common Stock

    2025-08-18+5,5256,054,223 total
  • Tax Payment

    Common Stock

    2025-08-18$4.06/sh1,498$6,0826,052,725 total
  • Tax Payment

    Common Stock

    2025-08-18$4.06/sh1,468$5,9606,057,419 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-08-181,9813,313 total
    Common Stock (1,981 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-08-187,36346,640 total
    Common Stock (7,363 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-08-185,52557,094 total
    Common Stock (5,525 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-08-186,16288,337 total
    Common Stock (6,162 underlying)
Footnotes (6)
  • [F1]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
  • [F3]The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.
  • [F4]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2024 and each March 10 thereafter, until fully vested.
  • [F5]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter.
  • [F6]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested.

Issuer

Cytek Biosciences, Inc.

CIK 0001831915

Entity typeother

Related Parties

1
  • filerCIK 0001874041

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:58 PM ET
Size
26.0 KB